Quantbot Technologies LP Lowers Stake in DaVita Inc. (NYSE:DVA)

Quantbot Technologies LP reduced its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 19.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 43,660 shares of the company's stock after selling 10,781 shares during the quarter. Quantbot Technologies LP owned about 0.05% of DaVita worth $6,529,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. bought a new stake in DaVita during the fourth quarter worth approximately $41,000. Quarry LP bought a new stake in DaVita during the third quarter worth approximately $60,000. Venturi Wealth Management LLC increased its stake in DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after acquiring an additional 152 shares during the last quarter. Versant Capital Management Inc increased its stake in DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after acquiring an additional 169 shares during the last quarter. Finally, Blue Trust Inc. increased its stake in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after acquiring an additional 131 shares during the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Trading Up 0.0 %

Shares of NYSE DVA traded up $0.03 during trading hours on Tuesday, reaching $149.27. The stock had a trading volume of 673,871 shares, compared to its average volume of 780,848. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The firm has a market cap of $11.94 billion, a price-to-earnings ratio of 13.90, a P/E/G ratio of 1.07 and a beta of 0.99. The business's fifty day moving average price is $158.87 and its two-hundred day moving average price is $157.62. DaVita Inc. has a 52-week low of $125.64 and a 52-week high of $179.60.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

DVA has been the subject of several recent analyst reports. Sanford C. Bernstein set a $184.00 target price on DaVita in a research report on Friday, February 21st. Cowen restated a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Barclays boosted their target price on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.